Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening

European Journal of Human Genetics

Volumn 23, Issue 4, 2015, Pages 459-465

  Ulph, Fiona ^a   Cullinan, Tim ^b   Qureshi, Nadeem ^c   Kai, Joe ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b East Staffordshire Clinical Commissioning Group   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY DISORDER; ARTICLE; CHILDHOOD DISEASE; CYSTIC FIBROSIS; DISTRESS SYNDROME; DNA DETERMINATION; EXTENDED FAMILY; FEMALE; HETEROZYGOTE DETECTION; HUMAN; INFANT; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN SCREENING; PREVALENCE; PRIORITY JOURNAL; SEMI STRUCTURED INTERVIEW; SICKLE CELL ANEMIA; TELEPHONE INTERVIEW; UNITED KINGDOM; ANEMIA, SICKLE CELL; ATTITUDE TO HEALTH; GENETIC COUNSELING; GENETIC SCREENING; GENETICS; GREAT BRITAIN; HETEROZYGOTE; MENTAL STRESS; PARENT; PSYCHOLOGY;

ANEMIA, SICKLE CELL; COMMUNICATION; CYSTIC FIBROSIS; FEMALE; GENETIC COUNSELING; GENETIC TESTING; GREAT BRITAIN; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PARENTS; STRESS, PSYCHOLOGICAL; TRUTH DISCLOSURE;

EID: 84924738393     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.126     Document Type: Article

References (42)

1. Centre for Disease Control and Prevention. Ten great public health achievements-United States, 2001-2010. MMWR Morb Mortal Wkly Rep 2011; 60: 619-623.
2. UK Newborn Screening Programme. www.newbornbloodspot.screening.nhs.uk/consent.
3. UK Newborn Screening Programme Centre. Standards and guidelines for newborn blood spot screening 2008. www.newbornbloodspot.screening.nhs.uk/standards.
4. Hargreaves KM, Stewart RJ, Oliver SR: Informed choice and public health screening for children: the case of blood spot screening. Health Expect 2005; 8: 161-171.
5. Locock L, Kai J: Parents' experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era. Br J Gen Pract 2008; 58: 161-168.
6. Kai J, Ulph F, Cullinan T, Qureshi N: Communication of carrier status information following universal screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice. Health Technol Assess 2009; 13: 1-106.
7. Ulph F, Cullinan T, Qureshi N, Kai J: Familial influences on antenatal and newborn haemoglobinopathy screening. Ethn Health 2011; 16: 361-373.
8. NIHR-Health Technology Assessment Programme. The provision of antenatal information for the NHS Newborn Bloodspot Screening Programme. Health Technology Assessment Programme Call 2011;HTA 11/62.
9. Brazier M, Cave E: Medicine Patients and the Law, 5th edn London: Penguin, 2011.
10. Pollitt R, Green A, McCabe A et al: Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assess 1997; 1: i-iv 1-202.
11. Gurian E, Kinnamon D, Henry J, Waisbren SE: Expanded newborn screening for biochemical disorders: the effect of a false-positive result. Pediatrics 2006; 117: 1915-1921.
12. Merelle ME, Nagelkerke AF, Lees CM, Dezateux C: Newborn Screening for cystic fibrosis. Cochrane Library 2002; 1.
13. Tluczek A, Mischler EH, Bowers B et al: Psychological impact of false-positive results when screening for cystic fibrosis. Pediatr Pulmonol Suppl 1991; 7: 29-37.
14. Fyro K, Bodegard G: Four-year follow-up of psychological reactions to false positive screening tests for congenital hypothyroidism. Acta Paediatr Scand 1987; 76: 107-114.
15. Green M: Vulnerable child syndrome and its variants. Pediatr Rev 1986; 8: 75-80.
16. Rothenberg MB, Sills EM: The PKU anxiety syndrome. J Am Acad Child Psychiatry 1968; 24: 65-70.
17. Waisbren SE, Albers S, Amato S et al: Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA 2003; 290: 2564-2572.
18. Dillard JP, Tluczek A: Information flow after a positive newborn screening for cystic fibrosis. J Pediatr 2005; 147: s94-s97.
19. Collins JL, La Pean A, O'Tool F et al: Factors that influence parents' experiences with results disclosure after newborn screening identifies genetic carrier status for cystic fibrosis or sickle cell hemoglobinopathy. Patient Educ Couns 2013; 90: 378-385.
20. Hayeems RZ, Bytautas JP, Miller FA: A sytematic review of the effects of disclosing carrier results generated through newborn screening. J Genet Couns 2008; 17: 538-549.
21. Parker H, Qureshi N, Ulph F, Kai J: Imparting carrier status results detected by universal newborn screening for sickle cell and cystic fibrosis in England: a qualitative study of current practice and policy. BMC Health Serv Res 2007; 7: 203-211.
22. Tluczek A, Koscik RL, Farrell PM, Rock MJ: Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment. Pediatrics 2005; 115: 1692-1703.
23. Lewis S, Curnow L, Ross M, Massie J: Parental attitudes to the identification of thier infants as carriers of cystic fibrosis by newborn screening. J Pediatr Child Health 2006; 42: 533-537.
24. Tluczek A, Mischler E, Farrell PM: Parents' knowledge of neonatal screening and response to false-positive cystic fibrosis testing. J Dev Behav Pediatr 1992; 13: 181-186.
25. Mischler EH, Wilfond BS, Fost N et al: Cystic fibrosis newborn screening: impact on reproductive behaviour and implications for genetic counseling. Pediatrics 1998; 102: 44-52.
26. Laird L, Dezateux C, Anionwu EN: Fortnightly review: neonatal screening for sickle cell disorders: what about the carrier infants? BMJ 1996; 313: 407-411.
27. La Pean A, Farrell MH: Initially misleading communication of carrier results after newborn genetic screening. Pediatrics 2005; 116: 1499-1505.
28. Tluczek A, Orland KM, Nick SW, Brown RL: Newborn screening an appeal for improved parent education. J Perinat Neonatal Nurs 2009; 23: 326-334.
29. Cutler D, Lleras-Muney A: Understanding differences in health behaviors by education. J Health Econ 2010; 29: 1-28.
30. Parsons EP, Clarke AJ, Bradley DM: Implications of carrier identification in newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal 2003; 88: 467-471.
31. Ciske DJ, Haavisto A, Laxova A, Rock LZ, Farrell PM: Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process. Pediatrics 2001; 107: 699-705.
32. Vernooij-van Langen AMM, Reijntjens S, van der Pal SM, Loeber G, Dompeling E, Dankert-Roelse JE: To know or not to know, disclosure of a newborn carrier screening test result for cystic fibrosis. Eur J Med Genet 2013; 56: 192-196.
33. Miller FA, Paynter M, Hayeems RZ et al: Understanding sickle cell carrier status identified through newborn screening: a qualitative study. Eur J Hum Genet 2010; 18: 303-308.
34. Ulph F, Cullinan T, Qureshi N, Kai J: Familial influences on antenatal and newborn haemoglobinopathy screening. Ethn Health 2011; 16: 361-375.
35. Buchbinder M, Timmermans S: Newborn screening for metabolic disorders: parental perceptions of the initial communication of results. Clin Pediatr (Phila) 2012; 51: 739-744.
36. Lincoln YS, Guba GE: Naturalistic Inquiry. California: Sage Publications, 1985.
37. Johnson JD, Donohue WA, Atkin CK, Johnson S: A comprehensive model of information seeking tests focusing on a technical organization. Sci Commun 1995; 16: 274-303.
38. Moran J, Quirk K, Duff A, Brownlee KG: Newborn screening for CF in a regional paediatric centre: the psychosical effects of false-positive IRT results on parents. J Cyst Fibros 2007; 6: 250-254.
39. Davis TC, Humiston SG, Arnold CL et al: Recommendations for effective newborn screening communication: results of focus groups with parents, providers, and experts. Pediatrics 2006; 117: S326-S340.
40. Lempert T, Oliver S, Stewart R, Dezateux C: Communication of carrier results following newborn blood spot screening: parents' and health professionals' experiences 2004.
41. Green J, Hewison J, Bekker H, Bryant L, Cuckle H: Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technol Assess 2004; 8: iii, ix-x 1-109.
42. Ciske DJ, Haavisto A, Laxova A, Rock LZM, Farrell PM: Genetic counselling and neonatal screening for cystic fibrosis: an assessment of the communication process. Pediatrics 2001; 107: 699-705.